1-20 of 260
Massimo Breccia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Shedding light on resistance to asciminib

Massimo Breccia
Journal: Blood
Blood (2024) 144 (6): 594–595.
https://doi.org/10.1182/blood.2024024851
Published: 2024
Journal Articles

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis

Ilaria Crespiatico, Mattia Zaghi, Cristina Mastini, Deborah D’Aliberti, Mario Mauri, Carl Mirko Mercado, Diletta Fontana, Silvia Spinelli, Valentina Crippa, Elena Inzoli, Beatrice Manghisi, Ivan Civettini, Daniele Ramazzotti, Valentina Sangiorgio, Michele Gengotti, Virginia Brambilla, Andrea Aroldi, Federica Banfi, Cristiana Barone, Roberto Orsenigo, Ludovica Riera, Mara Riminucci, Alessandro Corsi, Massimo Breccia, Alessandro Morotti, Daniela Cilloni, Aldo Roccaro, Antonio Sacco, Fabio Stagno, Marta Serafini, Federica Mottadelli, Giovanni Cazzaniga, Fabio Pagni, Roberto Chiarle, Emanuele Azzoni, Alessandro Sessa, Carlo Gambacorti-Passerini, Elena Maria Elli, Luca Mologni, Rocco Piazza
Journal: Blood
Blood (2024) 143 (14): 1399–1413.
https://doi.org/10.1182/blood.2023021349
Published: 2024
Includes: Supplemental data
Journal Articles

A traffic light for TFR by lineage-specific MRD

Massimo Breccia
Journal: Blood
Blood (2023) 142 (25): 2129–2130.
https://doi.org/10.1182/blood.2023022059
Published: 2023
Journal Articles

On the Children Side. Overview of 194 Outcomes from Gimema Registry of Conception/Pregnancy in Chronic Myeloid Leukemia (CML)

Elisabetta Abruzzese, Elena Chiara, Fausto Castagnetti, Mario Annunziata, Carlo Gambacorti-Passerini, Luigiana Luciano, Antonella Russo Rossi, Alessandra Iurlo, Isabella Capodanno, Valentina Giai, Mariella D'Adda, Fabio Stagno, Antonella Gozzini, Mario Tiribelli, Federica Sorà, Sara Galimberti, Monica Bocchia, Germana Beltrami, Carmen Fava, Maria Cristina Miggiano, Massimo Breccia, Marco Cerrano, Anna Rita Scortechini, Olga Mulas, Clementina Caracciolo, Stefana Impera, Claudio Fozza, Alessandra Malato, Lucia Mastrullo, Marzia Salvucci, Monia Lunghi, Filippo Gherlinzoni, Paolo De Fabritiis, Paola Fazi, Sonia Maria Orlando, Alfonso Piciocchi, Fabrizio Pane
Journal: Blood
Blood (2023) 142 (Supplement 1): 3178.
https://doi.org/10.1182/blood-2023-188305
Published: 2023
Journal Articles

Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients

Simona Bernardi, Silvia Mutti, Alessia Cavalleri, Claudia Ielo, Mirko Farina, Federica Re, Katia Bosio, Alessandro Leoni, Cristian Bonvicini, Nicola Polverelli, Enrico Morello, Vera Radici, Massimo Breccia, Elisabetta Abruzzese, Michele Malagola, Domenico Russo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3180.
https://doi.org/10.1182/blood-2023-185733
Published: 2023
Journal Articles

With up to 8 Years of Therapy, Asciminib (ASC) Monotherapy Demonstrated Continued Favorable Efficacy, Safety, and Tolerability in Patients (Pts) with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP) without the T315I Mutation: Final Results from the Phase 1 X2101 Study

Andreas Hochhaus, Dong-Wook Kim, Jorge Cortes, Koji Sasaki, Michael Mauro, Timothy P Hughes, Massimo Breccia, Moshe Talpaz, Hironobu Minami, Yeow Tee Goh, Daniel J. DeAngelo, Fabian Lang, Michael C. Heinrich, Valle Gomez G De Soria, Philipp le Coutre, Gessami Sanchez-Olle, Jomy Jose, Nathalie Pognan, Shruti Kapoor, Delphine Rea
Journal: Blood
Blood (2023) 142 (Supplement 1): 450.
https://doi.org/10.1182/blood-2023-187322
Published: 2023
Journal Articles

Full Treatment-Free Remission Outcome in Patients with Chronic Myeloid Leukemia in Chronic Phase Following One Year of Nilotinib De-Escalation: 96-Week Update of Dante Study

Alessandra Iurlo, Massimo Breccia, Fabio Stagno, Elisabetta Abruzzese, Fabrizio Pane, Immacolata Attolico, Paolo Sportoletti, Marco Cerrano, Sara Galimberti, Barbara Scappini, Maurizio Miglino, Sergio Siragusa, Isabella Capodanno, Diletta Valsecchi, Aurelio Pio Nardozza, Alessandra Misto, Paola Coco, Giuseppe Saglio, Gianantonio Rosti
Journal: Blood
Blood (2023) 142 (Supplement 1): 4534.
https://doi.org/10.1182/blood-2023-180131
Published: 2023
Journal Articles

Efficacy of Frontline Treatment with Initial Low-Dose Tyrosine-Kinase Inhibitors in Elderly Patients with Chronic Myeloid Leukemia: A “Campus CML” Study

Cristina Bucelli, Isabella Capodanno, Maria Cristina Miggiano, Francesco Cavazzini, Sabrina Leonetti Crescenzi, Sabina Russo, Ida Carmosino, Mario Annunziata, Federica SORA, Massimiliano Bonifacio, Luigiana Luciano, Giovanni Caocci, Giuseppina Loglisci, Chiara Elena, Francesca Lunghi, Rikard Mullai, Imma Attolico, Gianni Binotto, Elena Crisa', Paolo Sportoletti, Ambra Di Veroli, Anna Rita Scortechini, Anna Paola Leporace, Alessandro Maggi, Monica Crugnola, Fabio Stagno, Rosaria Sancetta, Pamela Murgano, Davide Rapezzi, Debora Luzi, Jolanda Donatella Vincelli, Sara Galimberti, Monica Bocchia, Carmen Fava, Alessandra Malato, Elisabetta Abruzzese, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Alessandra Iurlo, Mario Tiribelli, Roberto Latagliata
Journal: Blood
Blood (2023) 142 (Supplement 1): 3176.
https://doi.org/10.1182/blood-2023-186406
Published: 2023
Journal Articles

ELN Criteria for Cytoreduction Start Identify Patients with Polycythemia Vera at Higher Thrombotic Risk

Francesca Palandri, Giulia Benevolo, Elena Maria Elli, Roberto Latagliata, Giuseppe Auteri, Filippo Branzanti, Mario Tiribelli, Francesco Cavazzini, Alessia Tieghi, Nicola Polverelli, Alessandra D'Addio, Elisabetta Abruzzese, Federica Colombo, Marta Venturi, Francesco Ramundo, Rikard Mullai, Antonio Cuneo, Benedetto Bruno, Michele Cavo, Giuseppe Alberto Palumbo, Florian H Heidel, Massimo Breccia, Valerio De Stefano
Journal: Blood
Blood (2023) 142 (Supplement 1): 4527.
https://doi.org/10.1182/blood-2023-181553
Published: 2023
Journal Articles

International, Prospective Study Comparing Nilotinib Versus Imatinib with Early Switch to Nilotinib to Obtain Sustained Treatment-Free Remission in Patients with Chronic Myeloid Leukemia (SUSTRENIM trial): Analysis of the Eligibility to Treatment Discontinuation

Fabrizio Pane, Fausto Castagnetti, Alfonso Piciocchi, Elisabetta Abruzzese, Renato Bassan, Gianni Binotto, Massimiliano Bonifacio, Giovanni Caocci, Francesco Cavazzini, Giuseppe Cimino, Antonella Gozzini, Monia Lunghi, Roberto Marasca, Bruno Martino, Francesco Muriano, Gianantonio Rosti, Antonella Russo Rossi, Simona Sica, Agostino Tafuri, Daniele Vallisa, Monica Messina, Francesca Paola Paoloni, Paola Fazi, Peter E Westerweel, Jeroen J.W.M. Janssen, Giuseppe Saglio, Massimo Breccia
Journal: Blood
Blood (2023) 142 (Supplement 1): 3169.
https://doi.org/10.1182/blood-2023-182220
Published: 2023
Journal Articles

The Use of 2 nd Generation TKIs As First Line Therapy Does Not Prevent CML Related Deaths: Results of an Italian CML Campus Prospective Study in 1277 Patients Treated First Line with Imatinib or 2 nd Generation TKIs

Valentina Giai, Fabio Stagno, Tiziana Rosso, Fausto Castagnetti, Isabella Capodanno, Massimiliano Bonifacio, Mario Tiribelli, Sara Galimberti, Monica Bocchia, Antonella Gozzini, Giovanni Caocci, Andrea Patriarca, Giuseppe Lanzarone, Anna Guella, Federica Sorà, Luigiana Luciano, Anna Rita Scortechini, Nicola Di Renzo, Pellegrino Musto, Domenico Pastore, Alessandro Maggi, Carmen Fava, Vincenzo Pavone, Claudio Fozza, Giuseppina Spinosa, Angelo Michele Carella, Giuseppe Tarantini, Bruno Martino, Michele Pizzuti, Clara Mannarella, Fabio Saccona, Gianantonio Rosti, Patrizia Pregno, Massimo Breccia, Fabrizio Pane, Giovannino Ciccone, Giorgina Specchia, Giuseppe Saglio
Journal: Blood
Blood (2023) 142 (Supplement 1): 3168.
https://doi.org/10.1182/blood-2023-182981
Published: 2023
Journal Articles

Real World Outcome of Unfit Patients with Acute Myeloid Leukemia Treated with the Combination Venetoclax Plus Hypomethylating Agents in the Gimema AML2320 Observational Trial

Adriano Venditti, Alfonso Piciocchi, Stefano Soddu, Marco Frigeni, Raffaele Palmieri, Erika Borlenghi, Nicola Fracchiolla, Maria Paola Martelli, Ernesta Audisio, Giacomo Gianfaldoni, Calogero Vetro, Nicola di Rienzo, Daniela Esposito, Ambra Di Veroli, Carmine Selleri, Federica Gigli, Antonio Curti, Antonino Mulè, Catello Califano, Sara Bigliardi, Massimo Breccia, Claudio Fozza, Monica Bocchia, Albana Lico, Federico Simonetti, Elisabetta Pierdomenico, Francesco Buccisano, Maria Ilaria Del Principe, Luca Maurillo, Paola Fazi, Marco Vignetti, Felicetto Ferrara, Roberto Cairoli, Giuseppe Rossi, Alessandro Rambaldi
Journal: Blood
Blood (2023) 142 (Supplement 1): 1514.
https://doi.org/10.1182/blood-2023-178505
Published: 2023
Journal Articles

Asciminib (ASC) in Combination with Imatinib (IMA), Nilotinib (NIL), or Dasatinib (DAS) May be a Potential Treatment (Tx) Option in Patients (Pts) with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase or Accelerated Phase (Ph+ CML-CP/AP): Final Results from the Asciminib Phase 1 Study

Jorge Cortes, Fabian Lang, Delphine Rea, Andreas Hochhaus, Massimo Breccia, Yeow Tee Goh, Michael C. Heinrich, Timothy P Hughes, Jeroen J.W.M. Janssen, Philipp le Coutre, Hironobu Minami, Koji Sasaki, Daniel J. DeAngelo, Gessami Sanchez-Olle, Nathalie Pognan, Jomy Jose, Matthias Hoch, Michael Mauro
Journal: Blood
Blood (2023) 142 (Supplement 1): 868.
https://doi.org/10.1182/blood-2023-189270
Published: 2023
Journal Articles

First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis

Ilaria Crespiatico, Mattia Zaghi, Cristina Mastini, Deborah D'Aliberti, Mario Mauri, Carl Mirko Mercado, Diletta Fontana, Silvia Spinelli, Valentina Crippa, Elena Inzoli, Beatrice Manghisi, Ivan Civettini, Daniele Ramazzotti, Valentina Fabiola Ilenia Lavoro, Michele Gengotti, Virginia Brambilla, Andrea Aroldi, Federica Banfi, Cristiana Barone, Roberto Orsenigo, Ludovica Riera, Mara Riminucci, Alessandro Corsi, Massimo Breccia, Alessandro Morotti, Daniela Cilloni, Aldo Roccaro, Antonio Sacco, Fabio Stagno, Marta Serafini, Federica Mottadelli, Giovanni Cazzaniga, Fabio Pagni, Roberto Chiarle, Emanuele Azzoni, Alessandro Sessa, Carlo Gambacorti-Passerini, Elena Maria Elli, Luca Mologni, Rocco Piazza
Journal: Blood
Blood (2023) 142 (Supplement 1): 4135.
https://doi.org/10.1182/blood-2023-189094
Published: 2023
Journal Articles

Optimal Duration of CPX-351 Treatment and Best Timing for Consolidation with Allogeneic Stem Cell Transplantation: Evidence from a Large Real-World Italian Study

Fabio Guolo, Luana Fianchi, Maria Paola Martelli, Patrizia Chiusolo, Federico Lussana, Francesco Grimaldi, Federica Pilo, Michela Rondoni, Carla Fili, Debora Capelli, Massimo Breccia, Sara Mastaglio, Monica Bocchia, Monica Fumagalli, Sara Galimberti, Valentina Mancini, Anna Lina Piccioni, Luca Maurillo, Raffaele Palmieri, Andrea Corbingi, Calogero Vetro, Alessandra Sperotto, Federica Gigli, Patrizia Zappasodi, Antonio Mulé, Erika Borlenghi, Michelina Dargenio, Federica Lessi, Marco Cerrano, Alessandro Isidori, Lorenzo Brunetti, Cristina Papayannidis, Monia Lunghi, Caterina Alati, Samuele Gatani, Francesco Mannelli, Nicola Fracchiolla, Michele Gottardi, Roberto Cairoli, Felicetto Ferrara, Roberto Massimo Lemoli, Adriano Venditti, Livio Pagano, Elisabetta Todisco
Journal: Blood
Blood (2023) 142 (Supplement 1): 731.
https://doi.org/10.1182/blood-2023-189025
Published: 2023
Journal Articles

Propensity Score Matching Comparing Asciminib Versus Ponatinib in Chronic Myeloid Leukemia Patients Who Failed Prior Tyrosine Kinase Inhibitor Therapy

Maria Agustina Perusini, Camille Kockerols, Daniela Žáčková, Franck E. Nicolini, Fausto Castagnetti, Carolina Pavlovsky, Massimo Breccia, Delphine Rea, Carmen Fava, Mary Lynn Savoie, Christophe Bouvier, Petra Čičátková, Julien Bollard, Swe Mar Linn, Gopila Gupta, Emilia Scalzulli, Jiří Mayer, Peter E Westerweel, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 6360.
https://doi.org/10.1182/blood-2023-190293
Published: 2023
Journal Articles

Patients' Perception of Usability and Utility of a Digital Health Tool for Electronic Patient-Reported Outcomes Monitoring in Real-Life Hematology Practice: Evidence from the Gimema-Alliance Platform

Fabio Efficace, Mario Luppi, Leonardo Potenza, Francesco Sparano, Giovanni Caocci, Francesca Fazio, Massimo Breccia, Maria Teresa Petrucci, Andrea Patriarca, Thomas Baldi, Michelina Santopietro, Roberta Battistini, Agostino Tafuri, Gloria Margiotta Casaluci, Elisabetta Colaci, Davide Giusti, Valeria Pioli, Paolo De Fabritiis, Nicolina Rita Ardu, Pasquale Niscola, Olga Mulas, Claudio Fozza, Sergio Siragusa, Salvatrice Mancuso, Paola Boggione, Lorenzo De Paoli, Anna Paola Leporace, Maria Paola Bianchi, Ida Carmosino, Claudio Cartoni, Alice Di Rocco, Isabella Capodanno, Massimo Pini, Alessandra Romano, Paola Fazi, Marco Vignetti
Journal: Blood
Blood (2023) 142 (Supplement 1): 3714.
https://doi.org/10.1182/blood-2023-180574
Published: 2023
Journal Articles

Outcome of Patients with Chronic Myeloid Leukemia in Chronic Phase Showing Clinical Resistance to Frontline Treatment with Second Generation Tyrosine Kinase Inhibitors. an Italian Prospective Study from the CML Campus

Fabio Stagno, Valentina Giai, Patrizia Pregno, Gabriele Gugliotta, Tiziana Rosso, Fausto Castagnetti, Isabella Capodanno, Massimiliano Bonifacio, Mario Tiribelli, Sara Galimberti, Monica Bocchia, Antonella Gozzini, Giovanni Caocci, Andrea Patriarca, Giuseppe Lanzarone, Anna Guella, Simona Sica, Luigiana Luciano, Anna Rita Scortechini, Maria Pia Loglisci, Antonella Russo Rossi, Maria Rosaria Coppi, Alessandro Maggi, Maria Teresa Santeramo, Carmen Fava, Giuseppina Greco, Claudio Fozza, Giuseppina Spinosa, Grazia Sanpaolo, Bruno Martino, Michele Pizzuti, Giuseppe Pietrantuono, Fabio Saccona, Gianantonio Rosti, Massimo Breccia, Fabrizio Pane, Giovannino Ciccone, Giorgina Specchia, Giuseppe Saglio
Journal: Blood
Blood (2023) 142 (Supplement 1): 6363.
https://doi.org/10.1182/blood-2023-188523
Published: 2023
Journal Articles

Baseline Features, Treatment Choice and Early Frontline TKI Permanent Discontinuation in Younger Patients with Chronic Myeloid Leukemia: A “Campus CML” Study

Francesco Cavazzini, Isabella Capodanno, Maria Cristina Miggiano, Cristina Bucelli, Sabrina Leonetti Crescenzi, Sabina Russo, Ida Carmosino, Atelda Romano, Federica Sorà, Massimiliano Bonifacio, Luigiana Luciano, Giovanni Caocci, Maria Pia Loglisci, Chiara Elena, Francesca Lunghi, Rikard Mullai, Immacolata Attolico, Gianni Binotto, Elena Crisà, Paolo Sportoletti, Ambra Di Veroli, Anna Rita Scortechini, Anna Paola Leporace, Alessandro Maggi, Monica Crugnola, Fabio Stagno, Marco Santoro, Pamela Murgano, Davide Rapezzi, Debora Luzi, Jolanda Donatella Vincelli, Sara Galimberti, Monica Bocchia, Carmen Fava, Alessandra Malato, Elisabetta Abruzzese, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Alessandra Iurlo, Mario Tiribelli, Roberto Latagliata
Journal: Blood
Blood (2023) 142 (Supplement 1): 1811.
https://doi.org/10.1182/blood-2023-188934
Published: 2023
Journal Articles

Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: The "RAMP” Multicenter Prospective Study

Francesca Palandri, Elena Maria Elli, Alessandra Iurlo, Giuseppe Auteri, Malgorzata Monika Trawinska, Massimiliano Bonifacio, Francesco Mendicino, Roberto Latagliata, Camilla Mazzoni, Mattia Biondo, Valentina Sangiorgio, Daniele Cattaneo, Edoardo Tamellini, Elisabetta Abruzzese, Mauro Krampera, Stefana Impera, Bruno Garibaldi, Simona Paglia, Daniela Bartoletti, Nicola Vianelli, Michele Cavo, Florian H. Heidel, Massimo Breccia, Giovanni Caocci, Giuseppe A. Palumbo
Journal: Blood
Blood (2022) 140 (Supplement 1): 9726–9728.
https://doi.org/10.1182/blood-2022-165303
Published: 2022